Insmed INSM
NASDAQ INSM
$108.96 +0.37 (+0.34%)
As of: Oct 2, 2026 · 12:03 PM EDT

Insmed (INSM) Net Equity Issued and Repurchased (2012 - 2026)

Updated

Insmed's Net Equity Issued and Repurchased was $28.01 million in Q2 2026, down 96.5% from $793.83 million a year earlier and down 7.6% from the prior quarter.

Analysis

Insmed (INSM) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Insmed's Net Equity Issued and Repurchased was $58.06 million through Jun 30, 2026, down 95.1% year-over-year; for FY2025, it came in at $823.28 million, down 24.1% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 27.3% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $1.08 billion in FY2024 (+611.0%), $152.48 million in FY2023 (-47.8%), $292.15 million in FY2022 (+8.3%) and $269.89 million in FY2021 (+9.8%).
  • Quarterly Net Equity Issued and Repurchased has moved between -$256,000 (Q3 2025) and $793.83 million (Q2 2025) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased was higher in three of the last four quarters, with growth averaging 137.6%.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2025 (growth of 633.1%); the worst was Q2 2022 (a decline of 97.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Insmed 24.91 Bn 19.42 Bn 358.27 Mn 28.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.01 Mn
Mar 31, 2026 30.31 Mn
Sep 30, 2025 -256,000.00
Jun 30, 2025 793.83 Mn
Mar 31, 2025 29.70 Mn
Dec 31, 2024 -12,000.00
Sep 30, 2024 370.98 Mn
Jun 30, 2024 709.11 Mn
Mar 31, 2024 4.05 Mn
Dec 31, 2023 114.46 Mn
Jun 30, 2023 36.88 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 258.77 Mn
Sep 30, 2022 20.12 Mn
Jun 30, 2022 6.45 Mn
Mar 31, 2022 6.82 Mn
Jun 30, 2021 262.93 Mn
Mar 31, 2021 6.96 Mn
Dec 31, 2020 1,000.00
Sep 30, 2020 -47,000.00
API Access

Insmed Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=INSM&period=max&api_key=YOUR_API_KEY